Hodgkin's lymphoma following treatment with etanercept in ankylosing spondylitis.
Rheumatol Int
; 28(2): 185-7, 2007 Dec.
Article
em En
| MEDLINE
| ID: mdl-17622534
ABSTRACT
It has been well known that anti-TNF drugs might increase lymphoma risk in rheumatoid arthritis (RA), where the rate of lymphoma has already been increased. However, unlike RA, an increased rate of lymphoma has not been reported in ankylosing spondylitis (AS). Hereby, we present a case with AS developing Hodgkin's lymphoma (HL) following 6 months of etanercept treatment. Pathological analysis revealed mixed cellular type of HL. Although we report a single case, it should be kept in mind that anti-TNF drugs might cause lymphoma development not only in RA, but also in AS.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Espondilite Anquilosante
/
Imunoglobulina G
/
Doença de Hodgkin
/
Receptores do Fator de Necrose Tumoral
/
Antirreumáticos
Limite:
Adult
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2007
Tipo de documento:
Article